Equities

Irhythm Technologies Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Irhythm Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)144.21
  • Today's Change-4.20 / -2.83%
  • Shares traded491.93k
  • 1 Year change+28.54%
  • Beta1.0853
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

iRhythm Technologies, Inc. is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. The Company's principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. The Company provides Zio ambulatory cardiac monitoring services, including long-term continuous monitoring (LTCM), short-term continuous monitoring, and mobile cardiac telemetry (MCT) monitoring services, using a proprietary system that combines an FDA-cleared and CE-marked wire-free, patch-based, 14-day wearable biosensor that continuously records ECG data, with a proprietary FDA-cleared, CE-marked, Japan PDMA approved cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

  • Revenue in USD (TTM)702.57m
  • Net income in USD-51.46m
  • Incorporated2025
  • Employees2.00k
  • Location
    Irhythm Technologies Inc699 8th Street, Suite 600SAN FRANCISCO 94103United StatesUSA
  • Phone+1 (650) 632-5700
  • Fax+1 (302) 655-5049
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Haemonetics Corp1.32bn175.44m2.68bn3.02k15.872.979.322.043.643.6427.4019.460.5251.586.47436,081.706.995.418.306.5559.3253.2013.319.181.1512.690.57330.003.956.6042.6416.994.37--
Integer Holdings Corp1.83bn87.20m3.01bn11.00k35.841.7214.251.642.402.3951.7649.830.55785.044.83166,461.302.663.282.843.5427.1526.704.766.382.455.230.41120.0010.356.4135.805.8216.99--
ICU Medical Inc2.32bn-7.36m3.58bn15.00k--1.6818.251.54-0.3109-0.310994.3086.170.5522.2412.70154,690.90-0.206-0.2042-0.2351-0.230636.4733.82-0.3731-0.33261.191.620.3829--5.4413.47-296.86---3.18--
LivaNova PLC1.35bn-217.49m3.59bn2.90k--3.10--2.66-4.01-4.0124.6421.190.53112.586.60465,159.30-8.56-4.14-11.07-5.0368.5067.61-16.12-9.041.1210.220.273--8.662.94260.39--10.98--
TransMedics Group Inc566.35m90.47m4.44bn728.0054.5412.4838.227.832.382.4114.4810.400.65414.656.63777,958.8010.45-5.7311.37-6.2860.2862.3715.97-11.867.1331.190.5903--82.7479.64241.70--279.42--
Teleflex Inc3.19bn-327.85m4.59bn14.10k--1.20--1.44-7.35-7.3670.5586.480.41542.056.00226,240.30-4.274.58-4.695.0153.6754.77-10.2811.381.536.780.411419.742.453.26-80.38-31.404.250.00
Lantheus Holdings Inc1.53bn167.68m4.60bn808.0029.144.1119.813.022.382.3821.9016.880.70558.674.481,888,531.007.759.8710.5011.3362.2360.4410.9912.862.49--0.3370.0018.3234.59-4.3558.0629.27--
iRhythm Holdings, Inc702.57m-51.46m4.65bn2.00k--38.10--6.61-1.62-1.6222.113.780.737712.049.15351,286.50-5.40-20.12-6.21-24.3770.3568.61-7.32-23.904.50--0.8418--20.1322.508.20--19.06--
Envista Holdings Corp2.72bn47.00m4.75bn12.00k105.361.5329.131.750.2750.27516.1018.960.49314.626.86226,625.000.8523-2.141.01-2.5855.0256.701.73-5.212.046.700.318--8.327.11104.202.03-1.03--
Merit Medical Systems Inc1.48bn118.43m4.84bn7.40k41.803.1719.793.281.951.9524.3725.800.58982.397.38199,611.904.733.495.173.9348.4745.378.025.652.8614.410.3240.007.896.4027.4885.69-14.13--
Stevanato Group SpA1.39bn166.85m4.85bn5.52k26.192.5618.223.490.61130.61135.096.250.50582.952.65251,569.006.088.027.6310.9429.2731.0112.0113.241.3030.000.23866.821.7215.53-19.1324.6133.52--
Bruker Corp3.44bn-22.50m5.55bn11.40k--2.2427.861.61-0.1487-0.148722.6116.280.57051.675.71---0.12125.07-0.1556.7646.7049.41-0.21247.560.87397.790.426813.132.0811.57-119.89--4.344.56
Caris Life Sciences Inc-100.00bn-100.00bn5.82bn----12.16----------1.70------------------------9.36--0.4404--34.67--18.22------
Avantor Inc6.55bn-530.20m6.27bn13.50k--1.13--0.9577-0.7775-0.77759.628.160.54815.706.21485,348.20-4.442.78-5.173.1832.6533.77-8.095.001.183.610.41490.00-3.410.4913-174.52--15.90--
Glaukos Corp469.82m-87.61m6.29bn995.00--8.16--13.38-1.55-1.558.2813.410.48791.766.06472,180.90-9.10-11.24-9.92-12.0476.8773.54-18.65-36.684.47--0.0817--21.8510.10-8.70--5.93--
Data as of Feb 13 2026. Currency figures normalised to Irhythm Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

41.97%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 20253.04m9.44%
BlackRock Fund Advisorsas of 31 Dec 20252.34m7.27%
Sands Capital Management LLCas of 31 Dec 20251.70m5.28%
Artisan Partners LPas of 31 Dec 20251.51m4.69%
Capital Research & Management Co. (Global Investors)as of 31 Dec 20251.18m3.68%
Geode Capital Management LLCas of 31 Dec 2025858.41k2.66%
SSgA Funds Management, Inc.as of 31 Dec 2025764.84k2.37%
William Blair & Co. LLC (Investment Management)as of 30 Sep 2025740.72k2.30%
Eventide Asset Management LLCas of 31 Dec 2025692.49k2.15%
JPMorgan Investment Management, Inc.as of 31 Dec 2025685.66k2.13%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.